Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Odiparcil

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 137215-12-4, Odiparcil [inn], Fik1414zi8, Gsk 424323, 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-, 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one
    Molecular Formula
    C15H16O6S
    Molecular Weight
    324.4  g/mol
    InChI Key
    JRHNIQQUVJOPQC-AQNFWKISSA-N
    FDA UNII
    FIK1414ZI8
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-methyl-7-[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one
    2.1.2 InChI
    InChI=1S/C15H16O6S/c1-7-4-12(17)21-11-5-8(2-3-9(7)11)20-15-14(19)13(18)10(16)6-22-15/h2-5,10,13-16,18-19H,6H2,1H3/t10-,13+,14-,15-/m1/s1
    2.1.3 InChI Key
    JRHNIQQUVJOPQC-AQNFWKISSA-N
    2.1.4 Canonical SMILES
    CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O
    2.1.5 Isomeric SMILES
    CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H](CS3)O)O)O
    2.2 Other Identifiers
    2.2.1 UNII
    FIK1414ZI8
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 137215-12-4

    2. Odiparcil [inn]

    3. Fik1414zi8

    4. Gsk 424323

    5. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-beta-d-xylopyranosyl)oxy]-

    6. 4-methyl-7-(((2r,3r,4s,5s)-3,4,5-trihydroxytetrahydro-2h-thiopyran-2-yl)oxy)-2h-chromen-2-one

    7. Odiparcil [who-dd]

    8. Dsstox_cid_31428

    9. Dsstox_rid_97314

    10. Unii-fik1414zi8

    11. Dsstox_gsid_57639

    12. Schembl4515803

    13. Chembl2107763

    14. Dtxsid4057639

    15. Tox21_113853

    16. Zinc31597280

    17. 4-methyl-7-[(2r,3r,4s,5s)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one

    18. Db06609

    19. Gsk-424323

    20. Ncgc00253734-01

    21. Bo167288

    22. Sb 424323

    23. Cas-137215-12-4

    24. E98880

    25. Q27278001

    26. 4-methyl-7-(5-thio-beta-d-xylopyranosyloxy)-2h-chromen-2-one

    27. 4-methyl-2-oxo-2h-1-benzopyran-7-yl 5-thio-beta-d-xylopyranoside

    28. 2h-1-benzopyran-2-one, 4-methyl-7-[(5-thio-b-d-xylopyranosyl)oxy]-

    29. 4-methyl-7-(5-thio-.beta.-d-xylopyranosyloxy)-2h-chromen-2-one

    30. 7-((2r,3r,4s,5s)-tetrahydro-3,4,5-trihydroxy-2h-thiopyran-2-yloxy)-4-methyl-2h-chromen-2-one

    2.4 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 324.4 g/mol
    Molecular Formula C15H16O6S
    XLogP30.1
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count2
    Exact Mass324.06675940 g/mol
    Monoisotopic Mass324.06675940 g/mol
    Topological Polar Surface Area122 Ų
    Heavy Atom Count22
    Formal Charge0
    Complexity467
    Isotope Atom Count0
    Defined Atom Stereocenter Count4
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in atrial fibrillation, cardiovascular disorders, thrombosis, and venous thromboembolism.